Drug recall · July 29, 2026
Rising, Cyproheptadine Hydrochloride Syrup recall
Why: Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
- Lots / codes
Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.
- Quantity
- 74208 units
- Company
- Rising Pharma Holding, Inc., East Brunswick, NJ
- Distribution
- Nationwide U.S.A.
- Initiated
- July 13, 2026 · Voluntary: Firm initiated
- Classified
- July 23, 2026
- Reported
- July 29, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cyproheptadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.